GlobeNewswire Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 20, 2026 - 12:00 GMT

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported a positive outcome in its formal …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

TEL AVIV, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (TASE & NASDAQ: ENLT), a leading global renewable energy developer and an independent power producer, will release its financial results for the first quarter of 2026 before …

Distribution channels: Culture, Society & Lifestyle, Energy Industry ...

Published on April 20, 2026 - 12:00 GMT

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate ...

SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American Association …

Distribution channels: Technology ...

Published on April 20, 2026 - 12:00 GMT

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute ...

Le marquage CE au titre du Règlement européen sur les dispositifs médicaux (MDR de l’UE) a été obtenu pour Virtuoso®, la première plateforme de phaco-vitrectomie à double fonction de BVI, conçue pour offrir un contrôle avancé, une efficacité, une …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory ...

MHRA submission follows EMA validation of the VIZZ MAA in March 2026 Sixth ex-U.S. regulatory submission for VIZZ underscores accelerating global expansion SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) today announced …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten ...

Die CE-Kennzeichnung gemäß der Medizinprodukteverordnung der Europäischen Union (EU-MDR) wurde für Virtuoso® erteilt, die erste Phako-Vitrektomie-Plattform mit Doppelfunktion von BVI, die für fortschrittliche Kontrolle, Effizienz, Vielseitigkeit und …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Second candidate from Tenvie’s product engine to enter clinical development Phase 1 first-in-human study to evaluate single and multiple ascending doses of TNV108 in healthy volunteers Preliminary data expected in the second half of 2026 BRISBANE, Calif., …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Royale® lance « Là pour tout le monde », une nouvelle plateforme qui célèbre les moments qui comptent le plus pour les Canadiennes ...

TORONTO, 20 avr. 2026 (GLOBE NEWSWIRE) -- Depuis plus de six décennies, Royale® fait partie intégrante de la vie quotidienne des Canadiennes et des Canadiens. Du séchage des premières larmes au nettoyage des dégâts d’un repas familial chaotique, les …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on April 20, 2026 - 12:00 GMT

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable ...

100% of patients achieved rapid, sustained improvements across MG-ADL and QMG at 24 weeks, further increasing confidence in Phase 3 trial Totality of efficacy and safety data reinforces miv-cel’s differentiated and potential best-in-class profile for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 20, 2026 - 12:00 GMT

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 ...

DURHAM, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the independent Data Monitoring …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 20, 2026 - 12:00 GMT

ATTN SEVEN HILLS INVESTORS: Kaskela Law Firm Announces Investigation of Seven Hills Realty Trust (SEVN) and Encourages Current ...

PHILADELPHIA, April 20, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Seven Hills Realty Trust (NASDAQ: SEVN) (“Seven Hills”) on behalf of the company’s current shareholders. According to Kaskela Law’s managing director, …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

ATTN INDUSTRIAL LOGISTICS INVESTORS: Kaskela Law Firm Announces Investigation of Industrial Logistics Properties Trust (ILPT) and ...

PHILADELPHIA, April 20, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Industrial Logistics Properties Trust (NASDAQ: ILPT) (“ILPT”) on behalf of the company’s current shareholders. According to Kaskela Law’s managing director …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on April 20, 2026 - 12:00 GMT

Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent ...

MCLEAN, Va., April 20, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a leading provider of IT cybersecurity solutions and AI-driven innovations, today announced the release of a new interview featuring Kevin Kelly, …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on April 20, 2026 - 12:00 GMT

Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies

TORONTO, ON, April 20, 2026 (GLOBE NEWSWIRE) -- Max Immunity Clinic, a premier health management practice specializing in cellular energy restoration and advanced regenerative therapies, is celebrating its grand opening on April 24 and 25, 2026. Founded by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 20, 2026 - 12:00 GMT

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Updated AACR poster data show continued survival follow-up in heavily pre‑treated patients following a single intratumoral UNO injection Received US patent allowance covering proprietary gas delivery technology for UNO GARDEN CITY, N.Y., April 20, 2026 ( …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Royale® Launches “There for All”: A New Platform Celebrating the Moments That Matter Most to Canadians

TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- For more than six decades, Royale® has been woven into the fabric of the everyday lives of Canadians. From the first wipe of a tear to the spills of a chaotic family dinner, Royale products are trusted in life’s …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on April 20, 2026 - 12:00 GMT

Cole West Closes on 38 Homesites in Northern Utah for New Community

SYRACUSE, Utah, April 20, 2026 (GLOBE NEWSWIRE) -- Cole West, a privately-held, locally owned and operated, Utah-based real estate development company today announced that it has closed on 38 homesites for a new community called Lone Tree in Syracuse, Utah …

Distribution channels: Media, Advertising & PR, Real Estate & Property Management ...

Published on April 20, 2026 - 12:00 GMT

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

TORONTO, ONTARIO, April 20, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced today that it has filed a Rule 13e-3 Transaction Statement (the “Transaction Statement”) with the U.S. …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Lead Plaintiff Deadline of May 11, 2026 in Shareholder Class Action Lawsuits Against monday.com Ltd. (MNDY), Trip.com Group ...

ATLANTA, April 20, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: monday.com Ltd. (MNDY) The shareholder class action lawsuit filed against …

Distribution channels:

Published on April 20, 2026 - 12:00 GMT

Airsys Introduces Next-Generation LiquidRack™ Technology to Provide a Simpler Liquid Cooling Architecture for Retrofit, Edge, and ...

GREER, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Airsys, a global leader in mission-critical cooling for data centers, AI and high-performing digital infrastructure, today announced the next generation of LiquidRack™, a rack-level liquid cooling platform …

Distribution channels: Media, Advertising & PR ...